ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Burn Ointment Market Outlook 2021-2028: Key Players Profiles Including Johnson & Johnson, Pfizer Inc., Cipla Ltd., Mankind Pharma Ltd., Dr. Morepen Ltd. and GlaxoSmithKline PLC - ResearchAndMarkets.com

August 25, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Aug 25, 2021--

The “Burn Ointment Market, By Product Type, By Depth of Burn, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028” report has been added to ResearchAndMarkets.com’s offering.

Market players in the burn ointment market are focused on research and development activities to obtain approvals for new products or techniques associated with burn injuries, which could contribute to the growth of the global burn ointment market over the forecast period. For instance, in Oct 2020, Recce Pharmaceuticals Ltd announced that it has received Human Research Ethics Committee (HREC) approval to begin a Phase I/II clinical trial of its broad-spectrum antibiotic RECCE 327 on patients with infected burn wounds.

ADVERTISEMENT

Market players are focusing on product launches, which is expected to strengthen their position in the global burn ointment market. For instance, on May 1, 2020, LUMASOL, a new health tech player in the skincare industry, launched its first product lumasol, a broad-spectrum SPF 50 mist with a unique, translucent, and cruelty-free formula that helps prevent sun-related disease such as sunburns and ageing.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global burn ointment market globally. For instance, in May 2019, Vericel Corp., an American biopharmaceutical company announced an exclusive U.S. licensing and supply agreement with MediWound Ltd., a fully-integrated biopharmaceutical company for its NexoBrid biological product.

Key features of the study:

ADVERTISEMENT

  • This report provides an in-depth analysis of global burn ointment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
  • It includes potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global burn ointment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Smith & Nephew PLC, Wisconsin Pharmacal Company, Johnson & Johnson, Pfizer Inc., Cipla Ltd., Mankind Pharma Ltd., Dr. Morepen Ltd., and GlaxoSmithKline PLC.
  • The global burn ointment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts

Company Profiles

  • Smith & Nephew PLC*
  • Wisconsin Pharmacal Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Cipla Ltd.
  • Mankind Pharma Ltd.
  • Dr. Morepen Ltd.
  • GlaxoSmithKline PLC 

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Overview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Depth of Burn
  • Market Snippet, By End User
  • Market Snippet, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Porter’s Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario of Burn Ointments
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. COVID - 19 Impact Analysis

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Burn Ointments
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Burn Ointment Market, By Product Type, 2017-2028 (US$ Million)

  • Market Share Analysis, 2021 and 2028 (%)
  • Topical Antibiotics
  • Silver
  • Iodine

6. Global Burn Ointment Market, By Depth of Burn, 2017 - 2028 (US$ Million)

  • Market Share Analysis, 2021 and 2028 (%)
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns

7. Global Burn Ointment Market, By End User, 2017 - 2028 (US$ Million)

  • Market Share Analysis, 2021 and 2028 (%)
  • Hospitals
  • Specialty Clinics
  • Others

8. Global Burn Ointment Market, By Region, 2017 - 2028 (US$ Million)

9. Competitive Landscape

  • Company Profiles
  • Smith & Nephew PLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Wisconsin Pharmacal Company
  • Johnson & Johnson
  • Pfizer Inc.
  • Cipla Ltd.
  • Mankind Pharma Ltd.
  • Dr. Morepen Ltd.
  • GlaxoSmithKline PLC 

For more information about this report visit https://www.researchandmarkets.com/r/ngp1a6

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210825005567/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL SUPPLIES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 08/25/2021 10:53 AM/DISC: 08/25/2021 10:53 AM

http://www.businesswire.com/news/home/20210825005567/en